Cargando…
Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report
Statins are commonly used lipid lowering agents which play a pivotal role in reducing cardiovascular morbidity and mortality. Often well tolerated, these HMG-CoA reductase (HMGCR) inhibitors can sometimes cause severe muscle weakness and elevated creatinine kinase (CK) often labeled as statin intole...
Autores principales: | Upreti, Sunita, Fayyaz, Beenish, Bongu, Ramchandran P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374921/ https://www.ncbi.nlm.nih.gov/pubmed/30788073 http://dx.doi.org/10.1080/20009666.2019.1571882 |
Ejemplares similares
-
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
por: Lorenzo-Villalba, Noel, et al.
Publicado: (2021) -
Severe Anti-HMG-CoAR Necrotizing Autoimmune Myopathy Secondary to Statin Use
por: Pulipati, Priyanjali, et al.
Publicado: (2022) -
Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase (Anti-HMG CoA) Myopathy With Cardiac Involvement: Presentation, Diagnosis, and Management
por: Liu, Lisa, et al.
Publicado: (2022) -
Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins
por: Salar, Tooba, et al.
Publicado: (2023) -
Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
por: Würtz, Peter, et al.
Publicado: (2016)